person · Reporting owner

Hoffman Reid

Disclosed activity across 6 companies

Tapewire entity: 10683
SEC CIK: 0001519339

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Aurora Innovation, Inc.AUR · Entity 3489	Director	May 28, 2026	May 28, 2026
MICROSOFT CORPMSFT · Entity 1016	Director	September 10, 2026	September 11, 2026
Vor Biopharma Inc.VOR · Entity 4763	10% owner	October 17, 2025	October 21, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aurora Innovation, Inc.

Report date May 28, 2026 · Filed May 28, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2026-05-28 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-05-28 · Sale · Disposed 1,082,118 · Balance 0 F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3: Reflects securities held directly by Greylock 15.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2026-05-28 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2026-05-28 · Sale · Disposed 60,118 · Balance 0 F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4: Reflects securities held directly by Greylock 15-A.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2026-05-28 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-05-28 · Sale · Disposed 60,118 · Balance 0 F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5: Reflects securities held directly by Greylock 15 Principals.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	5,162,315	Reported balance Holding disclosure · report date 2026-05-28 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 5,162,315 F6: Reflects securities held directly by Reinvent Sponsor Y LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,550,646	Reported balance Holding disclosure · report date 2026-05-28 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 1,550,646 F7: Reflects securities held by Reprogrammed Interchange LLC ("Reprogrammed"). The reporting person may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. The reporting person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	674,719	Reported balance Holding disclosure · report date 2026-05-28 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 674,719 F8: Reflects securities held by Programmable Exchange LLC ("Programmable"). The reporting person may be deemed a beneficial owner of securities held by Programmable by virtue of his voting and investment power over such securities. The reporting person disclaims beneficial ownership of the securities held by Programmable, except to the extent of his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	Direct	354,669	Reported balance Holding disclosure · report date 2026-05-28 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 354,669

Filing footnotes · ownership attribution and instrument terms

F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein.

F3: Reflects securities held directly by Greylock 15.

F4: Reflects securities held directly by Greylock 15-A.

F5: Reflects securities held directly by Greylock 15 Principals.

F6: Reflects securities held directly by Reinvent Sponsor Y LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

F7: Reflects securities held by Reprogrammed Interchange LLC ("Reprogrammed"). The reporting person may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. The reporting person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F8: Reflects securities held by Programmable Exchange LLC ("Programmable"). The reporting person may be deemed a beneficial owner of securities held by Programmable by virtue of his voting and investment power over such securities. The reporting person disclaims beneficial ownership of the securities held by Programmable, except to the extent of his pecuniary interest therein.

MICROSOFT CORP

Report date September 10, 2026 · Filed September 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	17,182.471	Reported balance After 2026-09-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-09-10 · Grant · Acquired 31.692 · Balance 17,182.471 F1: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors.
Common StockSEC Table I · non-derivative	IndirectBy Living Trust	15,905	Reported balance Holding disclosure · report date 2026-09-10 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 15,905

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock.

F2: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate.

F3: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors.

Vor Biopharma Inc.

Report date October 17, 2025 · Filed October 21, 2025

Jointly reported with Reprogrammed Interchange LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,166,909	Last balance in matching sequence After 2025-10-21 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2025-10-17 · Sale · Disposed 24,689 · Balance 1,179,753 F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 2 · 2025-10-17 · Sale · Disposed 1,028 · Balance 1,178,725 F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 3 · 2025-10-20 · Sale · Disposed 11,616 · Balance 1,167,109 F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 4 · 2025-10-21 · Sale · Disposed 200 · Balance 1,166,909 F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Hippo Holdings Inc.

Report date August 02, 2021 · Filed August 03, 2021

Section 16 reporting ended · disclosed 2021-08-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	5,630,000	Reported balance After 2021-08-02 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2021-08-02 · Exercise / conversion · Acquired 5,630,000 · Balance 5,630,000 F1: 75% of such shares are subject to vesting in tranches of 25% if the volume weighted average price of the Issuer's shares of Common Stock equals or exceeds $12.50, $15.00, or $20.00, respectively, for any 20 trading days within a 30 trading day period on or prior to the tenth anniversary of the business combination of Reinvent Technology Partners Z (the former name of the Issuer) ("RTPZ") and Hippo Enterprises Inc. (the "Business Combination"). On August 2, 2031, any unvested shares will automatically vest. In the event the Issuer completes a transaction that results in a change of control, all unvested shares will vest immediately prior to the closing of such transaction. F2: On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination. F3: The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.
Class B ordinary sharesSEC Table II · derivative / convertible security	IndirectSee Footnote	0	Reported balance After 2021-08-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-08-02 · Exercise / conversion · Disposed 5,630,000 · Balance 0 F2: On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination. F3: The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: 75% of such shares are subject to vesting in tranches of 25% if the volume weighted average price of the Issuer's shares of Common Stock equals or exceeds $12.50, $15.00, or $20.00, respectively, for any 20 trading days within a 30 trading day period on or prior to the tenth anniversary of the business combination of Reinvent Technology Partners Z (the former name of the Issuer) ("RTPZ") and Hippo Enterprises Inc. (the "Business Combination"). On August 2, 2031, any unvested shares will automatically vest. In the event the Issuer completes a transaction that results in a change of control, all unvested shares will vest immediately prior to the closing of such transaction.

F2: On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination.

F3: The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

Joby Aviation, Inc.

Report date June 14, 2024 · Filed June 19, 2024

Section 16 reporting ended · disclosed 2024-06-19. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	102,603	Reported balance After 2024-06-14 transaction · row 1 1 source row Row 1 · 2024-06-14 · Exercise / conversion · Acquired 22,556 · Balance 102,603
Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2024-06-14 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2024-06-14 · Exercise / conversion · Disposed 22,556 · Balance 0 F3: Represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors (the "Annual Award"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 22, 2024, in each case, subject to Reporting Person's continued status as a Service Provider (as defined in the Issuer's 2021 Incentive Award Plan) through the applicable vesting date. Each RSU represents a contingent right to receive one share of Common Stock upon vesting.
Common StockSEC Table I · non-derivative	IndirectBy Reinvent Sponsor LLC	17,130,000	Reported balance Holding disclosure · report date 2024-06-14 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 17,130,000 F1: The securities are directly held by Reinvent Sponsor LLC ("Sponsor"). The Reporting Person may be deemed a beneficial owner of securities held by Sponsor by virtue of his shared control over and indirect pecuniary interest in Sponsor. The Reporting Person disclaims beneficial ownership of the securities held by Sponsor, except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Reprogrammed Interchange LLC	2,000,000	Reported balance Holding disclosure · report date 2024-06-14 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 2,000,000 F2: These securities are directly held by Reprogrammed Interchange LLC ("Reprogrammed"). On the basis of the Reporting Person's relationship with Reprogrammed, the Reporting Person may be deemed a beneficial owners of the securities held by Reprogrammed. The Reporting Person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The securities are directly held by Reinvent Sponsor LLC ("Sponsor"). The Reporting Person may be deemed a beneficial owner of securities held by Sponsor by virtue of his shared control over and indirect pecuniary interest in Sponsor. The Reporting Person disclaims beneficial ownership of the securities held by Sponsor, except to the extent of his pecuniary interest therein.

F2: These securities are directly held by Reprogrammed Interchange LLC ("Reprogrammed"). On the basis of the Reporting Person's relationship with Reprogrammed, the Reporting Person may be deemed a beneficial owners of the securities held by Reprogrammed. The Reporting Person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F3: Represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors (the "Annual Award"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 22, 2024, in each case, subject to Reporting Person's continued status as a Service Provider (as defined in the Issuer's 2021 Incentive Award Plan) through the applicable vesting date. Each RSU represents a contingent right to receive one share of Common Stock upon vesting.

LINKEDIN CORP

Report date August 17, 2016 · Filed December 09, 2016

Jointly reported with Reid Hoffman & Michelle Yee Living Trust

Section 16 reporting ended · disclosed 2016-12-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	0	Last balance in matching sequence After 2016-08-17 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2016-08-17 · Conversion · Acquired 900,000 · Balance 900,000 F1: 900,000 shares of Class B Common Stock were converted into 900,000 shares of Class A Common Stock at the election of the Reporting Person and had no expiration date. F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust. Row 2 · 2016-08-17 · Gift · Disposed 900,000 · Balance 0 F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	13,589,899	Reported balance After 2016-08-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-08-17 · Conversion · Disposed 900,000 · Balance 13,589,899 F1: 900,000 shares of Class B Common Stock were converted into 900,000 shares of Class A Common Stock at the election of the Reporting Person and had no expiration date. F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2016-12-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-12-08 · Disposition to issuer · Disposed 13,589,899 · Balance 0 F3: The shares of Class B Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration") and had no expiration date. F4: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.

Filing footnotes · ownership attribution and instrument terms

F1: 900,000 shares of Class B Common Stock were converted into 900,000 shares of Class A Common Stock at the election of the Reporting Person and had no expiration date.

F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.

F3: The shares of Class B Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration") and had no expiration date.

F4: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 10, 2026 Filed Sep 11, 2026 22:03 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	31.692	$0.00	$0.00	Disclosure SEC source: 0000789019-26-000200 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,182.471 Underlying: Common Stock · 31.692 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
September 05, 2026 Filed Sep 8, 2026 22:03 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	187.613	$0.00	$0.00	Disclosure SEC source: 0000789019-26-000176 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,150.779 Underlying: Common Stock · 187.613 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
June 11, 2026 Filed Jun 12, 2026 22:03 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	39.453	$0.00	$0.00	Disclosure SEC source: 0000789019-26-000122 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,963.167 Underlying: Common Stock · 39.453 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:02 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	224.998	$0.00	$0.00	Disclosure SEC source: 0000789019-26-000098 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,923.714 Underlying: Common Stock · 224.998 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
May 28, 2026 Filed May 28, 2026 19:28 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	60,118	$7.27	$437,304.34	Disclosure SEC source: 0001519339-26-000006 · wk-form4_1780010880.xml · nonDerivative · entry 3 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
May 28, 2026 Filed May 28, 2026 19:28 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	60,118	$7.27	$437,304.34	Disclosure SEC source: 0001519339-26-000006 · wk-form4_1780010880.xml · nonDerivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
May 28, 2026 Filed May 28, 2026 19:28 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	1,082,118	$7.27	$7,871,434.54	Disclosure SEC source: 0001519339-26-000006 · wk-form4_1780010880.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
May 21, 2026 Filed May 22, 2026 18:11 UTC	Aurora Innovation, Inc. AUR · Entity 3489	GrantClass A Common Stock	36,547	$0.00	$0.00	Disclosure SEC source: 0001519339-26-000004 · wk-form4_1779487888.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,669 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. 100% of the RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the day prior to the date of the Issuer's next annual stockholders meeting following May 21, 2026, in each case, subject to the reporting person's continued service through the applicable vesting date. Read SEC document
May 18, 2026 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	17,382	$7.51	$130,455.39	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 9 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 60,118 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.50 to $7.5150 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
May 18, 2026 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	17,382	$7.51	$130,455.39	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 8 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 60,118 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.50 to $7.5150 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
May 18, 2026 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	312,882	$7.51	$2,348,241.99	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 7 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,082,118 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.50 to $7.5150 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
May 15, 2026 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	274,925	$7.81	$2,146,669.39	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 6 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 77,500 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.70 to $7.98 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
May 15, 2026 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	274,925	$7.81	$2,146,669.39	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 5 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 77,500 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.70 to $7.98 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
May 15, 2026 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	4,948,637	$7.81	$38,639,947.42	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 4 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,395,000 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.70 to $7.98 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
March 12, 2026 Filed Mar 13, 2026 22:01 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	37.726	$0.00	$0.00	Disclosure SEC source: 0000789019-26-000057 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,698.716 Underlying: Common Stock · 37.726 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
January 30, 2026 Filed Feb 3, 2026 23:03 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	217.876	$0.00	$0.00	Disclosure SEC source: 0000789019-26-000015 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,660.99 Underlying: Common Stock · 217.876 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
December 11, 2025 Filed Dec 12, 2025 23:20 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	30.891	$0.00	$0.00	Disclosure SEC source: 0000789019-25-000122 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,443.114 Underlying: Common Stock · 30.891 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
December 04, 2025 Filed Dec 5, 2025 23:02 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	194.971	$0.00	$0.00	Disclosure SEC source: 0000789019-25-000100 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,412.223 Underlying: Common Stock · 194.971 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
October 31, 2025 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	ConversionClass B Common Stock · Derivative	352,425	$0.00	$0.00	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · derivative · entry 16 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Class A Common Stock · 352,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
October 31, 2025 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	ConversionClass B Common Stock · Derivative	352,425	$0.00	$0.00	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · derivative · entry 15 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Class A Common Stock · 352,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
October 31, 2025 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	ConversionClass B Common Stock · Derivative	6,343,637	$0.00	$0.00	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · derivative · entry 14 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Class A Common Stock · 6,343,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
October 31, 2025 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	ConversionClass A Common Stock	352,425	Not disclosed	Not disclosed	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 3 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 352,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
October 31, 2025 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	ConversionClass A Common Stock	352,425	Not disclosed	Not disclosed	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 352,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
October 31, 2025 Filed May 19, 2026 20:05 UTC	Aurora Innovation, Inc. AUR · Entity 3489	ConversionClass A Common Stock	6,343,637	Not disclosed	Not disclosed	Disclosure SEC source: 0001519339-26-000002 · wk-form4_1779235525.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 6,343,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election, and has no expiration date. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
October 21, 2025 Filed Oct 21, 2025 17:45 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	200	$30.08	$6,015.00	Disclosure SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,166,909 F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 20, 2025 Filed Oct 21, 2025 17:45 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	11,616	$30.05	$349,101.46	Disclosure SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,167,109 F3 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 17, 2025 Filed Oct 21, 2025 17:45 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	1,028	$31.00	$31,868.00	Disclosure SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,178,725 F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 17, 2025 Filed Oct 21, 2025 17:45 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	24,689	$30.22	$746,118.86	Disclosure SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179,753 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 16, 2025 Filed Oct 17, 2025 18:33 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	2,021	$30.45	$61,549.15	Disclosure SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,204,442 F5 · price: This transaction was executed in multiple trades at prices ranging from $30.05 to $30.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:33 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	7,894	$32.77	$258,712.43	Disclosure SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,206,463 F4 · price: This transaction was executed in multiple trades at prices ranging from $32.51 to $33.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:33 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	48,910	$32.05	$1,567,364.97	Disclosure SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,214,357 F3 · price: This transaction was executed in multiple trades at prices ranging from $31.51 to $32.505. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:33 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	14,851	$31.05	$461,117.61	Disclosure SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,263,267 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.505 to $31.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 14, 2025 Filed Oct 15, 2025 18:32 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	33,668	$30.32	$1,020,786.83	Disclosure SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,278,118 F5 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 13, 2025 Filed Oct 15, 2025 18:32 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	2,334	$33.09	$77,225.76	Disclosure SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,311,786 F4 · price: This transaction was executed in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 13, 2025 Filed Oct 15, 2025 18:32 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	19,672	$32.36	$636,560.35	Disclosure SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,314,120 F3 · price: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 10, 2025 Filed Oct 15, 2025 18:32 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	40,983	$30.97	$1,269,132.86	Disclosure SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333,792 F1 · price: This transaction was executed in multiple trades at prices ranging from $30.68 to $31.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 09, 2025 Filed Oct 10, 2025 17:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	15,042	$32.41	$487,439.02	Disclosure SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,374,775 F5 · price: This transaction was executed in multiple trades at prices ranging from $32.26 to $32.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 09, 2025 Filed Oct 10, 2025 17:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	33,842	$31.92	$1,080,172.34	Disclosure SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389,817 F4 · price: This transaction was executed in multiple trades at prices ranging from $31.26 to $32.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 08, 2025 Filed Oct 10, 2025 17:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	14,336	$34.34	$492,285.34	Disclosure SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,423,659 F3 · price: This transaction was executed in multiple trades at prices ranging from $34.20 to $34.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 08, 2025 Filed Oct 10, 2025 17:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	60,926	$33.75	$2,056,471.83	Disclosure SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,995 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.20 to $34.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 07, 2025 Filed Oct 8, 2025 17:20 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	27,624	$33.84	$934,710.53	Disclosure SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,498,921 F5 · price: This transaction was executed in multiple trades at prices ranging from $33.70 to $34.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 06, 2025 Filed Oct 8, 2025 17:20 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	18,156	$37.77	$685,830.19	Disclosure SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,526,545 F4 · price: This transaction was executed in multiple trades at prices ranging from $37.59 to $38.18 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 06, 2025 Filed Oct 8, 2025 17:20 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	34,847	$37.12	$1,293,565.94	Disclosure SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544,701 F3 · price: This transaction was executed in multiple trades at prices ranging from $36.59 to $37.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 06, 2025 Filed Oct 8, 2025 17:20 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	17,760	$36.00	$639,391.97	Disclosure SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579,548 F1 · price: This transaction was executed in multiple trades at prices ranging from $35.59 to $36.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	4,701	$38.14	$179,316.82	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 8 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,597,308 F10 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to $38.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	3,200	$37.37	$119,593.92	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 7 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,602,009 F9 · price: This transaction was executed in multiple trades at prices ranging from $36.88 to $37.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	5,300	$42.32	$224,290.70	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 6 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,605,209 F8 · price: This transaction was executed in multiple trades at prices ranging from $42.00 to $42.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	13,001	$40.13	$521,706.73	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 5 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,610,509 F7 · price: This transaction was executed in multiple trades at prices ranging from $39.86 to $40.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	7,700	$39.57	$304,710.56	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 4 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,623,510 F6 · price: This transaction was executed in multiple trades at prices ranging from $39.20 to $39.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	1,513	$38.38	$58,064.55	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,631,210 F5 · price: This transaction was executed in multiple trades at prices ranging from $37.85 to $38.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.